Bio-Techne
TECH
$77.19
Share price
-0.08%
Change (1 day)
-5.51%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $0.70 B
According to Bio-Techne's latest financial reports the company's total liabilities are $0.70 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-06-30 | $0.67 B | 13.2% |
| 2022-06-30 | $0.59 B | -14.16% |
| 2021-06-30 | $0.69 B | 7.01% |
| 2020-06-30 | $0.64 B | -10.08% |
| 2019-06-30 | $0.71 B | 39.81% |
| 2018-06-30 | $0.51 B | -15.52% |
| 2017-06-30 | $0.60 B | 143.14% |
| 2016-06-30 | $0.25 B | 15.65% |
| 2015-06-30 | $0.21 B | 221.94% |
| 2014-06-30 | $67.22 M | 65.76% |
| 2013-06-30 | $40.55 M | -9.64% |
| 2012-06-30 | $44.88 M | 42.27% |
| 2011-06-30 | $31.54 M | 85.31% |
| 2010-06-30 | $17.02 M | 9.67% |
| 2009-06-30 | $15.52 M | -23.3% |
| 2008-06-30 | $20.23 M | 17.72% |
| 2007-06-30 | $17.19 M | -43% |
| 2006-06-30 | $30.16 M | 10.11% |
| 2005-06-30 | $27.39 M | -2.29% |
| 2004-06-30 | $28.03 M | 5.16% |
| 2003-06-30 | $26.66 M | -15.98% |
| 2002-06-30 | $31.73 M | -16.2% |
| 2001-06-30 | $37.86 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $51.47 B | 7,182.31% | 🇺🇸 USA |
 Becton Dickinson BDX | $28.50 B | 3,933.56% | 🇺🇸 USA |
 General Electric GE | $132.83 B | 18,694.56% | 🇺🇸 USA |
 Danaher DHR | $29.95 B | 4,138.15% | 🇺🇸 USA |
 Qiagen QGEN | $2.20 B | 212.16% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $28.3 M | -96.00% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $3.55 B | 403.51% | 🇺🇸 USA |